Briefing
ALTAIR: trifluridine/tipiracil versus placebo when ctDNA becomes positive after resection of colorectal cancer
Phase 3 randomized trial of trifluridine/tipiracil versus placebo in patients with resected colorectal cancer who test ctDNA-positive without radiographic recurrence. ClinicalTrials.gov lists the study as completed.
- Design: Phase 3 · Completed